Is there a case for targeting hormone replacement therapy for osteoporosis at the menopause?
Stevenson
J C
JC
Wynn Department of Metabolic Medicine, Imperial College School of Medicine, London, UK.
D015519:Bone Density; D001941:Breast Diseases / Q000139:chemically induced; D003327:Coronary Disease / Q000517:prevention & control; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D005260:Female; D005598:Fractures, Spontaneous / Q000517:prevention & control; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000503:physiopathology / Q000517:prevention & control*; D018570:Risk Assessment